LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway
Authors
Keywords
LIM and SH3 protein 1, Glioblastoma, Temozolomide, PI3K/AKT pathway
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-07-06
DOI
10.1186/s12885-018-4649-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
- (2018) Shang-Yu Chou et al. BMC CANCER
- Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development
- (2017) Hua-fu Zhao et al. Molecular Cancer
- Paving the path for invasion: The polyedric role of LASP1 in cancer
- (2017) Vitalba Ruggieri et al. TUMOR BIOLOGY
- LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway
- (2016) ZhiZhen Li et al. CANCER LETTERS
- Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1)
- (2016) Marcel Endres et al. Oncotarget
- Loss of the 14-3-3σ is essential for LASP1-mediated colorectal cancer progression via activating PI3K/AKT signaling pathway
- (2016) Ziyun Shao et al. Scientific Reports
- LASP1-S100A11 axis promotes colorectal cancer aggressiveness by modulating TGFβ/Smad signaling
- (2016) Ya Niu et al. Scientific Reports
- Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide
- (2015) Khaled Messaoudi et al. DRUG DISCOVERY TODAY
- Prospects of immune checkpoint modulators in the treatment of glioblastoma
- (2015) Matthias Preusser et al. Nature Reviews Neurology
- LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex
- (2015) N Duvall-Noelle et al. ONCOGENE
- Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration
- (2015) Amelie Hailer et al. Oncotarget
- LASP1 Is a HIF1 Target Gene Critical for Metastasis of Pancreatic Cancer
- (2014) T. Zhao et al. CANCER RESEARCH
- LIM and SH3 Protein 1 Induces TGF -Mediated Epithelial-Mesenchymal Transition in Human Colorectal Cancer by Regulating S100A4 Expression
- (2014) H. Wang et al. CLINICAL CANCER RESEARCH
- Tumor suppressor miR-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the MAPK and PI3K/AKT pathway
- (2014) Lijun Xu et al. Journal of Translational Medicine
- miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway
- (2013) Hui Wang et al. EUROPEAN JOURNAL OF CANCER
- LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma
- (2012) Hui Wang et al. EUROPEAN JOURNAL OF CANCER
- Current clinical development of PI3K pathway inhibitors in glioblastoma
- (2012) P. Y. Wen et al. NEURO-ONCOLOGY
- Recent Advances in Therapy for Glioblastoma
- (2010) Jennifer Clarke et al. ARCHIVES OF NEUROLOGY
- Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1
- (2010) L. Zhao et al. GUT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now